Altria Group (MO) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
2 Apr, 2026Executive summary
Annual meeting scheduled for May 14, 2026, will be held virtually, allowing shareholders to vote and ask questions online.
Key business includes electing 10 directors, ratifying the external auditor, and an advisory vote on executive compensation.
Leadership transition announced: Sal Mancuso to become CEO and Heather Newman to become CFO after the meeting.
Company vision focuses on transitioning adult smokers to smoke-free products, expanding internationally, and exploring non-nicotine growth.
2025 marked by strong financial performance, dividend increases, and significant cash returns to shareholders.
Voting matters and shareholder proposals
Shareholders will vote on electing 10 director nominees, ratifying PricewaterhouseCoopers LLP as auditor, and a non-binding advisory vote on executive compensation.
Board recommends voting FOR all director nominees, FOR auditor ratification, and FOR the say-on-pay proposal.
Shareholders can submit proposals and director nominations for future meetings following established procedures.
Board of directors and corporate governance
Board consists of 12 directors, with 10 standing for election; 9 of 10 nominees are independent.
Board diversity: 70% gender and ethnic diversity, average tenure 5.8 years, average age 64.9.
Separate roles for Board Chair and CEO; all committees are composed solely of independent directors.
Board succession planning and refreshment emphasized, with ongoing evaluation of skills and diversity.
Comprehensive governance guidelines, codes of conduct, and robust director onboarding and education programs in place.
Latest events from Altria Group
- Virtual annual meeting to elect directors, ratify auditor, and vote on executive pay.MO
Proxy filing2 Apr 2026 - Accelerating smoke-free growth, innovation, and shareholder value with global expansion.MO
Consumer Analyst Group of New York Conference (CAGNY) 202618 Feb 2026 - 2025 adjusted EPS up 4.4% to $5.42, up to $10.2B returned, 2026 EPS guided at $5.56–$5.72.MO
Q4 20253 Feb 2026 - Net earnings up 51.9% to $5.93B on IQOS gain; NJOY and on! offset smokeable declines.MO
Q2 20242 Feb 2026 - Q3 adjusted EPS up 7.8%, 2024 guidance reaffirmed, and $600M cost-saving plan launched.MO
Q3 202417 Jan 2026 - 2024 saw robust EPS growth and cash returns, but illicit e-vapor clouds smoke-free outlook.MO
Q4 20249 Jan 2026 - Driving smoke-free innovation, global expansion, and strong returns amid regulatory challenges.MO
Consumer Analyst Group of New York Conference 20258 Jan 2026 - Q1 2025 adjusted EPS up 6% as e-vapor impairment and illicit market pressures persist.MO
Q1 202521 Dec 2025 - Annual meeting to vote on directors, auditor, compensation, and new incentive plans.MO
Proxy Filing1 Dec 2025